February 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Ruzanna Papyan on Neuroblastoma Risk Stratification in Real-World Settings

Ruzanna Papyan/LinkedIn

Jan 20, 2026, 15:53

Ruzanna Papyan on Neuroblastoma Risk Stratification in Real-World Settings

Ruzanna Papyan, Chief of Pediatric Oncology Department at PCBDC, Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia, shared on LinkedIn:

”Check out our new article, “Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries,” that has just been just published!

This work reflects a truly international collaboration and a shared commitment to adapting neuroblastoma risk stratification to real-world settings.

Read the article here.

Grateful for the collaboration, the shared vision, and the ongoing efforts to improve outcomes for children with neuroblastoma globally”

Article: Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project

Authors: Wendy London, Gabriela Villanueva, Derek Shyr, Jaques van Heerden, Soad Fuentes-Alabi, Raya Saab, Derek Harrison, Ruzanna Papyan, Hoa Thi Kim Nguyen, Dolly Noun, Joyce Kambugu, Jelena Rascon, Miklos Garami, Dongjing Guo, Paige Kao, Arlene Naranjo, Julie R. Park, Susan L. Cohn, Carlos Rodriguez-Galindo, Katherine K. Matthay

Ruzanna Papyan on Neuroblastoma Risk Stratification in Real-World Settings